Kelmar
Patricia
Kelmar
Senior Director, Health Care Campaigns, U.S. PIRG Education Fund
Kelmar
Patricia
SCOTUS action will limit generic drug competition
U.S. Supreme Court on Monday declined to review a federal circuit court decision that imperils a critical method that many generic drug makers use to win approval. The court denied a petition of certiorari in Teva Pharmaceuticals USA, Inc. V GlaxoSmithKline LLC, Et. Al., allowing the divided lower court's decision to stand. This action can have dramatically limit competition from lower-priced generic and biosimilar medicines.
NEW REPORT: Rx patent abuse tactics block generic drugs
New report explains how drug companies manipulate patents to prevent competition
Interview opportunity: New CMS guidance for arbitrators of out-of-network surprise billing payment disputes
Expert on ‘No Surprises Act’ available to explain potential negative impact on patients, consumers
Consumer Protection Week: 6 days of helpful advice
From scams to medical bills to airline refunds, PIRG is providing tips and tools to help Americans address common consumer issues.
New Year’s resolutions to make your wallet fatter and your information safer
Our consumer protection team offers some ways to keep your money and information safer in 2023.
NEWS RELEASE: National solution needed to put brakes on ambulance surprise bills
New report documents the high cost of emergency ground transportation
Release: New policy in effect erasing paid medical debt from credit reports
Consumer tips on how to check your credit report accuracy
Release: As bills from 2022 medical care arrive in mailboxes, patients should know their rights
Patients who received medical care in January and February are starting to receive their medical bills for those services. That’s why, in recognition of National Consumer Protection Week, it’s timely to remind people to check their bills carefully and make sure they know their new legal protections against surprise billing.
Medical providers challenging patient-protecting No Surprises Act in court
U.S. Public Interest Research Group (U.S. PIRG) moved to file an amicus brief urging the court to uphold the rules implementing the No Surprises Act, arguing that the regulations reflect the language and intent of the Act to keep health care costs down.